Boston Scientific’s stock surged 40.6% in the past year, far outpacing the broader market. This growth stems from strong ...

The stock's fall snapped a two-day winning streak.

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

Boston Scientific BSX has witnessed strong momentum in the past year. Shares of the company have risen 42.4% compared with 8.5% growth of the industry during the same time frame. The S&P 500 Composite ...

We’re a month into the year, and there’s so much excitement to come in the Boston-area food and drink world. Below, we’re tracking some of the forthcoming restaurants, bars, bakeries ...

Founders know the mantra: make data-driven decisions. In recent years, the scientific approach to nurturing start-ups—developing hypotheses, collecting evidence that either supports or refutes ...

The Food and Drug Administration issued a notice on Friday classifying its recall of the Boston Scientific Accolade pacemaker devices as the most serious type of recall. To date, 832 injuries and ...

Boston Scientific, Ireland’s leading medical device employer, has made significant investments in its Irish sites over the past 30 years. Boston Scientific is one of the world leaders in medical ...

Boston Scientific has gained a duo of CE markings in the European Union (EU) for its navigation enabled Farawave NAV Ablation Catheter for paroxysmal atrial fibrillation (AF) treatment and its new ...

The Farapulse Farawave catheter and Faraview software. [Image courtesy of Boston Scientific] Boston Scientific (NYSE: BSX) + announced today that it received CE mark for its navigation-enabled ...